This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Subscribe To Our Newsletter & Stay Updated
